ID   TTF2_HUMAN              Reviewed;        1162 AA.
AC   Q9UNY4; A8K4Q2; O75921; Q5T2K7; Q5VVU8; Q8N6I8;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 2.
DT   28-JUN-2023, entry version 189.
DE   RecName: Full=Transcription termination factor 2;
DE            EC=3.6.4.-;
DE   AltName: Full=Lodestar homolog;
DE   AltName: Full=RNA polymerase II termination factor;
DE   AltName: Full=Transcription release factor 2;
DE            Short=F2;
DE            Short=HuF2;
GN   Name=TTF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=9748214; DOI=10.1074/jbc.273.40.25541;
RA   Liu M., Xie Z., Price D.H.;
RT   "A human RNA polymerase II transcription termination factor is a SWI2/SNF2
RT   family member.";
RL   J. Biol. Chem. 273:25541-25544(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH CDC5L,
RP   IDENTIFICATION AS PART OF THE SPLICEOSOME, AND VARIANT HIS-1155.
RX   PubMed=12927788; DOI=10.1016/s0006-291x(03)01486-4;
RA   Leonard D., Ajuh P., Lamond A.I., Legerski R.J.;
RT   "hLodestar/HuF2 interacts with CDC5L and is involved in pre-mRNA
RT   splicing.";
RL   Biochem. Biophys. Res. Commun. 308:793-801(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLU-167.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=10455150; DOI=10.1074/jbc.274.35.24779;
RA   Hara R., Selby C.P., Liu M., Price D.H., Sancar A.;
RT   "Human transcription release factor 2 dissociates RNA polymerases I and II
RT   stalled at a cyclobutane thymine dimer.";
RL   J. Biol. Chem. 274:24779-24786(1999).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15125840; DOI=10.1016/s1097-2765(04)00234-5;
RA   Jiang Y., Liu M., Spencer C.A., Price D.H.;
RT   "Involvement of transcription termination factor 2 in mitotic repression of
RT   transcription elongation.";
RL   Mol. Cell 14:375-385(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-883, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-908, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-883, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-143, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: DsDNA-dependent ATPase which acts as a transcription
CC       termination factor by coupling ATP hydrolysis with removal of RNA
CC       polymerase II from the DNA template. May contribute to mitotic
CC       transcription repression. May also be involved in pre-mRNA splicing.
CC       {ECO:0000269|PubMed:10455150, ECO:0000269|PubMed:12927788,
CC       ECO:0000269|PubMed:15125840, ECO:0000269|PubMed:9748214}.
CC   -!- SUBUNIT: Interacts with CDC5L. Part of the spliceosome.
CC       {ECO:0000269|PubMed:12927788}.
CC   -!- INTERACTION:
CC       Q9UNY4; Q99459: CDC5L; NbExp=5; IntAct=EBI-2322921, EBI-374880;
CC       Q9UNY4-2; Q9UKD1: GMEB2; NbExp=3; IntAct=EBI-11980463, EBI-948296;
CC       Q9UNY4-2; Q99081-3: TCF12; NbExp=3; IntAct=EBI-11980463, EBI-11952764;
CC       Q9UNY4-2; P15884-3: TCF4; NbExp=3; IntAct=EBI-11980463, EBI-13636688;
CC       Q9UNY4-2; Q15025: TNIP1; NbExp=3; IntAct=EBI-11980463, EBI-357849;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15125840}. Nucleus
CC       {ECO:0000269|PubMed:15125840}. Note=Cytoplasmic during interphase.
CC       Relocates to the nucleus as cells enter mitosis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UNY4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UNY4-2; Sequence=VSP_015370, VSP_015371;
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF073771; AAC64044.1; -; mRNA.
DR   EMBL; AF080255; AAD49435.1; -; mRNA.
DR   EMBL; AK291017; BAF83706.1; -; mRNA.
DR   EMBL; AL391476; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL445231; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC030058; AAH30058.1; -; mRNA.
DR   CCDS; CCDS892.1; -. [Q9UNY4-1]
DR   RefSeq; NP_003585.3; NM_003594.3. [Q9UNY4-1]
DR   RefSeq; XP_016858044.1; XM_017002555.1. [Q9UNY4-1]
DR   AlphaFoldDB; Q9UNY4; -.
DR   SMR; Q9UNY4; -.
DR   BioGRID; 114036; 181.
DR   IntAct; Q9UNY4; 64.
DR   MINT; Q9UNY4; -.
DR   STRING; 9606.ENSP00000358478; -.
DR   GlyGen; Q9UNY4; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UNY4; -.
DR   MetOSite; Q9UNY4; -.
DR   PhosphoSitePlus; Q9UNY4; -.
DR   BioMuta; TTF2; -.
DR   DMDM; 73920148; -.
DR   EPD; Q9UNY4; -.
DR   jPOST; Q9UNY4; -.
DR   MassIVE; Q9UNY4; -.
DR   MaxQB; Q9UNY4; -.
DR   PaxDb; Q9UNY4; -.
DR   PeptideAtlas; Q9UNY4; -.
DR   ProteomicsDB; 85342; -. [Q9UNY4-1]
DR   ProteomicsDB; 85343; -. [Q9UNY4-2]
DR   Antibodypedia; 1775; 202 antibodies from 26 providers.
DR   DNASU; 8458; -.
DR   Ensembl; ENST00000369466.9; ENSP00000358478.3; ENSG00000116830.12. [Q9UNY4-1]
DR   GeneID; 8458; -.
DR   KEGG; hsa:8458; -.
DR   MANE-Select; ENST00000369466.9; ENSP00000358478.3; NM_003594.4; NP_003585.3.
DR   UCSC; uc001egy.4; human. [Q9UNY4-1]
DR   AGR; HGNC:12398; -.
DR   CTD; 8458; -.
DR   DisGeNET; 8458; -.
DR   GeneCards; TTF2; -.
DR   HGNC; HGNC:12398; TTF2.
DR   HPA; ENSG00000116830; Low tissue specificity.
DR   MIM; 604718; gene.
DR   neXtProt; NX_Q9UNY4; -.
DR   OpenTargets; ENSG00000116830; -.
DR   PharmGKB; PA37063; -.
DR   VEuPathDB; HostDB:ENSG00000116830; -.
DR   eggNOG; KOG4439; Eukaryota.
DR   GeneTree; ENSGT00940000162718; -.
DR   HOGENOM; CLU_000315_2_2_1; -.
DR   InParanoid; Q9UNY4; -.
DR   OMA; IVSQWTN; -.
DR   OrthoDB; 200191at2759; -.
DR   PhylomeDB; Q9UNY4; -.
DR   TreeFam; TF316297; -.
DR   PathwayCommons; Q9UNY4; -.
DR   SignaLink; Q9UNY4; -.
DR   SIGNOR; Q9UNY4; -.
DR   BioGRID-ORCS; 8458; 425 hits in 1173 CRISPR screens.
DR   ChiTaRS; TTF2; human.
DR   GeneWiki; TTF2; -.
DR   GenomeRNAi; 8458; -.
DR   Pharos; Q9UNY4; Tbio.
DR   PRO; PR:Q9UNY4; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9UNY4; protein.
DR   Bgee; ENSG00000116830; Expressed in sural nerve and 145 other tissues.
DR   ExpressionAtlas; Q9UNY4; baseline and differential.
DR   Genevisible; Q9UNY4; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005681; C:spliceosomal complex; IEA:UniProtKB-KW.
DR   GO; GO:0008023; C:transcription elongation factor complex; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008094; F:ATP-dependent activity, acting on DNA; IDA:FlyBase.
DR   GO; GO:0140658; F:ATP-dependent chromatin remodeler activity; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IBA:GO_Central.
DR   GO; GO:0006353; P:DNA-templated transcription termination; TAS:ProtInc.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; TAS:ProtInc.
DR   CDD; cd18072; DEXHc_TTF2; 1.
DR   CDD; cd18793; SF2_C_SNF; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 3.40.50.10810; Tandem AAA-ATPase domain; 1.
DR   InterPro; IPR002464; DNA/RNA_helicase_DEAH_CS.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR038718; SNF2-like_sf.
DR   InterPro; IPR000330; SNF2_N.
DR   InterPro; IPR010666; Znf_GRF.
DR   PANTHER; PTHR45626:SF17; TRANSCRIPTION TERMINATION FACTOR 2; 1.
DR   PANTHER; PTHR45626; TRANSCRIPTION TERMINATION FACTOR 2-RELATED; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF00176; SNF2-rel_dom; 1.
DR   Pfam; PF06839; zf-GRF; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS00690; DEAH_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51999; ZF_GRF; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; DNA-binding; Helicase;
KW   Hydrolase; Isopeptide bond; Metal-binding; mRNA processing; mRNA splicing;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Spliceosome; Transcription; Transcription regulation;
KW   Transcription termination; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1162
FT                   /note="Transcription termination factor 2"
FT                   /id="PRO_0000074376"
FT   DOMAIN          583..786
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          995..1157
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   ZN_FING         6..46
FT                   /note="GRF-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01343"
FT   REGION          97..116
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          142..358
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          388..407
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          459..503
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          871..890
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           737..740
FT                   /note="DEAH box"
FT   COMPBIAS        142..219
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        220..242
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        261..277
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        298..314
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        459..486
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         6
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01343"
FT   BINDING         9
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01343"
FT   BINDING         32
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01343"
FT   BINDING         37
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01343"
FT   BINDING         596..603
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MOD_RES         460
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         883
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         908
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   CROSSLNK        143
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         635..676
FT                   /note="DSCDFTSHGTLIICPASLIHHWKNEVEKRVNSNKLRVYLYHG -> GRQKCL
FT                   NSLPFPTSFEPPKRGTSSAKKGHLWSYLITLLENQY (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_015370"
FT   VAR_SEQ         677..1162
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_015371"
FT   VARIANT         167
FT                   /note="K -> E (in dbSNP:rs998532)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_023393"
FT   VARIANT         213
FT                   /note="K -> R (in dbSNP:rs7535524)"
FT                   /id="VAR_034431"
FT   VARIANT         256
FT                   /note="E -> G (in dbSNP:rs34334470)"
FT                   /id="VAR_061234"
FT   VARIANT         1134
FT                   /note="K -> R (in dbSNP:rs41276572)"
FT                   /id="VAR_061235"
FT   VARIANT         1155
FT                   /note="D -> H (in dbSNP:rs34236116)"
FT                   /evidence="ECO:0000269|PubMed:12927788"
FT                   /id="VAR_061236"
FT   CONFLICT        64
FT                   /note="L -> P (in Ref. 2; AAD49435)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80
FT                   /note="R -> G (in Ref. 2; AAD49435)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        675
FT                   /note="H -> R (in Ref. 1; AAC64044)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1162 AA;  129588 MW;  858BAA22B2D2D5C9 CRC64;
     MEEVRCPEHG TFCFLKTGVR DGPNKGKSFY VCRADTCSFV RATDIPVSHC LLHEDFVVEL
     QGLLLPQDKK EYRLFFRCIR SKAEGKRWCG SIPWQDPDSK EHSVSNKSQH ASETFHHSSN
     WLRNPFKVLD KNQEPALWKQ LIKGEGEEKK ADKKQREKGD QLFDQKKEQK PEMMEKDLSS
     GLVPKKKQSV VQEKKQEEGA EIQCEAETGG THKRDFSEIK SQQCQGNELT RPSASSQEKS
     SGKSQDVQRE SEPLREKVTQ LLPQNVHSHN SISKPQKGGP LNKEYTNWEA KETKAKDGPS
     IQATQKSLPQ GHFQERPETH SVPAPGGPAA QAAPAAPGLS LGEGREAATS SDDEEEDDVV
     FVSSKPGSPL LFDSTLDLET KENLQFPDRS VQRKVSPASG VSKKVEPSDP VARRVYLTTQ
     LKQKKSTLAS VNIQALPDKG QKLIKQIQEL EEVLSGLTLS PEQGTNEKSN SQVPQQSHFT
     KTTTGPPHLV PPQPLPRRGT QPVGSLELKS ACQVTAGGSS QCYRGHTNQD HVHAVWKITS
     EAIGQLHRSL ESCPGETVVA EDPAGLKVPL LLHQKQALAW LLWRESQKPQ GGILADDMGL
     GKTLTMIALI LTQKNQEKKE EKEKSTALTW LSKDDSCDFT SHGTLIICPA SLIHHWKNEV
     EKRVNSNKLR VYLYHGPNRD SRARVLSTYD IVITTYSLVA KEIPTNKQEA EIPGANLNVE
     GTSTPLLRIA WARIILDEAH NVKNPRVQTS IAVCKLQACA RWAVTGTPIQ NNLLDMYSLL
     KFLRCSPFDE FNLWRSQVDN GSKKGGERLS ILTKSLLLRR TKDQLDSTGR PLVILPQRKF
     QLHHLKLSED EETVYNVFFA RSRSALQSYL KRHESRGNQS GRSPNNPFSR VALEFGSEEP
     RHSEAADSPR SSTVHILSQL LRLRQCCCHL SLLKSALDPM ELKGEGLVLS LEEQLSALTL
     SELRDSEPSS TVSLNGTFFK MELFEGMRES TKISSLLAEL EAIQRNSASQ KSVIVSQWTN
     MLKVVALHLK KHGLTYATID GSVNPKQRMD LVEAFNHSRG PQVMLISLLA GGVGLNLTGG
     NHLFLLDMHW NPSLEDQACD RIYRVGQQKD VVIHRFVCEG TVEEKILQLQ EKKKDLAKQV
     LSGSGESVTK LTLADLRVLF GI
//
